PRICE Act

The PRICE Act, also known as Bill 118 s 3161, is a piece of legislation currently being considered by the US Congress. The purpose of this bill is to address the issue of rising prescription drug prices in the United States.

The PRICE Act aims to increase transparency in the pharmaceutical industry by requiring drug manufacturers to provide detailed information on the costs associated with producing and marketing their medications. This information would then be made publicly available in order to give consumers a better understanding of why drug prices are increasing.

Additionally, the bill includes provisions to prevent drug manufacturers from engaging in anti-competitive practices that could drive up prices. This includes measures to prevent companies from blocking generic drug competition and from engaging in price gouging. Overall, the PRICE Act is designed to promote greater accountability and fairness in the pharmaceutical industry in order to help lower prescription drug prices for American consumers. It is currently being debated in Congress and has garnered support from both Democrats and Republicans who are concerned about the rising cost of healthcare in the United States.